ArticleNPJ breast cancer2025
Body composition metrics as a determinant of trastuzumab deruxtecan related toxicity and response.
Shiran Yaacobi Peretz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it